Health Condition 1: F411- Generalized anxiety disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Clinically diagnosed patients of Izterab-i-Nafsani Umoomi. 2) Patients in age group of 18 to 65 years 3) All genders 4) Patients who are ready to sign the informed consent, follow the protocol and are willing to participate in clinical study voluntarily
Exclusion criteria
Exclusion criteria: 1) Panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. 2) Patients below 18 years and above 65 years 3) History of substance abuse: Caffeine, Alcohol, drug intoxication 4) Patient who fails to follow up 5) Patient who fails to give written consent 6) Known cases of hyperthyroidism, cardiovascular diseases, renal diseases, and liver diseases. 7) Pregnant and lactating mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Anxiety Rating Scale (HAM-A)Timepoint: 42 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Vegetative manifestations (increased heart rate, diaphoresis, tremor, or dry mouth) Symptoms in the chest cavity (respiratory symptoms, feeling of tightness, chest pain, abdominal discomfort) Mental symptoms (dizziness, derealization, fear of losing control, fear of dying) General symptoms (hot or cold flashes, paresthesias) Symptoms of tension (muscle tension, agitation, foreign body sensation in throat) Other nonspecific symptoms (exaggerated startle response, lack of concentration, irritability, difficulty falling asleep) Timepoint: 42 Days | — |
Countries
India
Contacts
Regional Research Institute of Unani Medicine (RRIUM), Srinagar